The use of nonradiolabelled steroid infusions to investigate the origin of oestrone sulphate in postmenopausal women. 1986

M J Reed, and C T Noel, and D L Jones, and H S Jacobs, and M J Scanlon, and V H James

Infusion of nonradiolabelled dehydroepiandrosterone sulphate (DHA-S) has been used to investigate the possible formation of oestrone sulphate via a sulphated conjugate of androstenedione. The metabolic clearance rate (MCR) of DHA-S also was measured and the mean value (25 1/24h) was similar to values reported using isotopic techniques. Although conversion of DHA-S to 5-androstenediol, a steroid with oestrogenic properties, was detected during infusion of DHA-S, there were no significant increases in plasma levels of conjugated androstenedione or oestrone sulphate. The MCR's oestrone sulphate measured using infusion of nonradiolabelled steroid in two menopausal women were 99 1/24h and 121 1/24h. For one woman, the production rate of oestrone sulphate, calculated from the conversion of oestrone and oestradiol to oestrone sulphate (151 nmol/day) was similar to the measured production rate of oestrone sulphate (144 nmol/day). It is concluded that in menopausal women, oestrone sulphate is derived from conversion of oestrone and oestradiol with no formation occurring via conjugated androstenedione.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D011714 Pyrans Pyran
D011753 Pyrones Keto-pyrans.
D004970 Estrone An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women. Folliculin (Hormone),Estrone, (+-)-Isomer,Estrone, (8 alpha)-Isomer,Estrone, (9 beta)-Isomer,Estrovarin,Kestrone,Unigen,Wehgen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000734 Androstenediols Unsaturated androstane derivatives which are substituted with two hydroxy groups in any position in the ring system.
D000735 Androstenedione A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL. 4-Androstene-3,17-dione,delta-4-Androstenedione,4 Androstene 3,17 dione,delta 4 Androstenedione

Related Publications

M J Reed, and C T Noel, and D L Jones, and H S Jacobs, and M J Scanlon, and V H James
November 1992, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
M J Reed, and C T Noel, and D L Jones, and H S Jacobs, and M J Scanlon, and V H James
November 1988, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
M J Reed, and C T Noel, and D L Jones, and H S Jacobs, and M J Scanlon, and V H James
June 1987, British journal of obstetrics and gynaecology,
M J Reed, and C T Noel, and D L Jones, and H S Jacobs, and M J Scanlon, and V H James
November 1980, Clinical endocrinology,
M J Reed, and C T Noel, and D L Jones, and H S Jacobs, and M J Scanlon, and V H James
March 2000, BJOG : an international journal of obstetrics and gynaecology,
M J Reed, and C T Noel, and D L Jones, and H S Jacobs, and M J Scanlon, and V H James
May 2007, The Journal of steroid biochemistry and molecular biology,
M J Reed, and C T Noel, and D L Jones, and H S Jacobs, and M J Scanlon, and V H James
April 1984, Maturitas,
M J Reed, and C T Noel, and D L Jones, and H S Jacobs, and M J Scanlon, and V H James
September 1977, The Biochemical journal,
M J Reed, and C T Noel, and D L Jones, and H S Jacobs, and M J Scanlon, and V H James
July 1994, The Journal of steroid biochemistry and molecular biology,
M J Reed, and C T Noel, and D L Jones, and H S Jacobs, and M J Scanlon, and V H James
September 1982, The Veterinary record,
Copied contents to your clipboard!